NeoGenomics Announced That Subsidiary Neogenomics Laboratories Will Appeal The Preliminary Injunction Issued By The U.S. District Court For The Middle District Of North Carolina

NeoGenomics, Inc. -2.41% Pre

NeoGenomics, Inc.





0.00% Pre

The Initial Determination Is That Natera, Inc. Demonstrated A Likelihood That Products Using Radar Technology Infringe One Natera, Inc. Patent. The Order Specifically Allows Patients Already Using Radar To Continue Their Use. In Addition, The Order Explicitly Allows Research Projects And Studies That Are In Progress, As Well As Clinical Trials That Are In Progress Or Have Been Approved, To Continue.

Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via